10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-053259`
Period End Date	20200930
Filing Date	20201112
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	tyme-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 55 Cash Flow Statement 45 Stockholders Equity 27

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.70M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$396.96K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$932.34K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$481.64K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$981.95K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.81M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.08M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.59K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.18K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$150.30K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$17.33K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total assets	`Assets`	$22.10M	USD	Point-in-time
Total assets	`Assets`	$29.50M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	130.17M	shares	Point-in-time
Accounts payable and other current liabilities (including $163,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$4.38M	USD	Point-in-time
Accounts payable and other current liabilities (including $163,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	123.31M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$380.72K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	130.17M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$392.29K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$783.79K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.80M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$518.12K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$174.75K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$54.66K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$19.83K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.75M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.06M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.25M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$3.64M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$790.23K	USD	Point-in-time
Total liabilities	`Liabilities`	$10.48M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.60M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 130,172,441 issued and outstanding at September 30, 2020, 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$12.33K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 130,172,441 issued and outstanding at September 30, 2020, 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$13.02K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$137.98M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$126.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-123.49M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.10M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$29.50M	USD	Point-in-time

Income Statement 55 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$249.00K	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$138.00K	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$97.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$341.00K	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.91M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.42M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.13M	USD	1 Quarter
General and administrative (including $138,000, $97,000, $341,000 and $249,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.61M	USD	1 Quarter
General and administrative (including $138,000, $97,000, $341,000 and $249,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$6.51M	USD	2 Qtrs
General and administrative (including $138,000, $97,000, $341,000 and $249,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$5.67M	USD	2 Qtrs
General and administrative (including $138,000, $97,000, $341,000 and $249,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.12M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$15.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$12.42M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$6.25M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-15.09M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-12.42M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.25M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-81.15K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.02M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-489.57K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$2.77M	USD	2 Qtrs
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$67.26K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$17.51K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$7.01K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$147.50K	USD	2 Qtrs
Interest expense	`InterestExpense`	$29.24K	USD	1 Quarter
Interest expense	`InterestExpense`	$25.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$62.22K	USD	2 Qtrs
Interest expense	`InterestExpense`	$55.36K	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$3.10M	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$119.17K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$470.60K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-582.85K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.32M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.68M	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	128.05M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	126.32M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.95M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.91M	shares	2 Qtrs

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-9.32M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-15.68M	USD	2 Qtrs
Depreciation	`Depreciation`	$2.59K	USD	2 Qtrs
Depreciation	`Depreciation`	$2.59K	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$3.07M	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.95M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-81.15K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.02M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-489.57K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$2.77M	USD	2 Qtrs
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-295.45K	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$535.38K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-595.71K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-500.30K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-147.22K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-132.97K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-443.61K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.55M	USD	2 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-242.65K	USD	2 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-183.91K	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-636.64K	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.02M	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-17.32K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-34.83K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.57M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.76M	USD	2 Qtrs
Insurance note payments	`InsuranceNotePayments`	$597.34K	USD	2 Qtrs
Insurance note payments	`InsuranceNotePayments`	$343.37K	USD	2 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$11.17M	USD	2 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$5.81M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.46M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.57M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.30M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.01M	USD	2 Qtrs
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.31M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.40M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.31M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.40M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Interest	`InterestPaidNet`	$62.22K	USD	2 Qtrs
Interest	`InterestPaidNet`	$55.36K	USD	2 Qtrs

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	130.17M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.45M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$883.93K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.07M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.32M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.68M	USD	2 Qtrs
Balance, at end	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	130.17M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.